Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 256.10%11.71M | -20.42%3.2M | 615.98%1.26M | 805.19%4.17M | 2,726.44%3.08M | -25.67%3.29M | 552.53%4.02M | -167.71%-244K | -119.41%-592.04K | -72.60%109.04K |
| Net income from continuing operations | 19.79%-17.99M | -14.56%-10.56M | -5.21%-2.63M | 66.36%-1.48M | 47.36%-3.33M | -610.07%-22.44M | -263.73%-9.22M | -35.78%-2.5M | -919.97%-4.39M | -8,768.90%-6.33M |
| Operating gains losses | ---- | ---- | --0 | -127.29%-32.25K | -58.65%904.25K | 444.91%5.67M | 265.66%3.25M | 151.17%120K | 753.01%118.18K | 2,297.70%2.19M |
| Depreciation and amortization | 4.61%15.88M | 3.80%4.02M | 4.51%4.01M | 5.79%4.11M | 4.32%3.74M | 58.21%15.18M | 9.45%3.87M | 63.08%3.83M | 108.87%3.88M | 94.44%3.59M |
| Asset impairment expenditure | --5.02M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Remuneration paid in stock | -93.25%47K | -108.93%-5K | -97.46%10K | -92.50%17.55K | 87.17%24.45K | 80.96%696K | -49.91%56K | 433.80%393K | 239.72%233.94K | -89.98%13.07K |
| Deferred tax | -100.36%-1.67M | -24,533.33%-733K | -92.05%-459K | -1.84%-257.83K | 35.47%-223.17K | 72.40%-835K | -99.59%3K | 84.31%-239K | 77.28%-253.17K | 68.97%-345.84K |
| Other non cashItems | -66.35%2.17M | -118.57%-854K | -133.57%-140K | 437.38%1.26M | 59.78%1.91M | 146.91%6.44M | 129.51%4.6M | -19.79%417K | -35.30%233.55K | 23.07%1.19M |
| Change In working capital | 678.11%8.27M | 394.01%7.18M | 120.60%468K | 233.78%559.95K | 131.72%61.05K | -132.46%-1.43M | -63.17%1.45M | -411.14%-2.27M | -131.55%-418.55K | 87.95%-192.46K |
| -Change in receivables | -119.30%-22K | 27.34%857K | 53.07%-222K | 7.45%-86.59K | -7,639.08%-570.41K | -92.08%114K | -75.96%673K | 41.31%-473K | 81.09%-93.57K | 112.45%7.57K |
| -Change in inventory | 291.52%4.38M | 220.38%1.25M | 396.47%1.6M | 133.71%196K | 1,134.85%1.34M | -191.21%-2.29M | -187.57%-1.04M | -147.24%-538K | -170.16%-581.42K | 79.93%-129.58K |
| -Change in prepaid assets | 79.53%-35K | -136.91%-179K | 178.32%242K | -26.19%106.97K | 58.33%-204.97K | -130.17%-171K | 250.44%485K | -512.69%-309K | -83.14%144.91K | -713.75%-491.91K |
| -Change in payables and accrued expense | 330.13%3.94M | 293.11%5.25M | -20.48%-1.15M | 208.07%343.57K | -219.72%-504.57K | 932.82%916K | 377.23%1.34M | -312.65%-952K | -16.20%111.53K | 143.43%421.48K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 256.10%11.71M | -20.42%3.2M | 615.98%1.26M | 805.19%4.17M | 2,726.44%3.08M | -25.67%3.29M | 552.53%4.02M | -167.71%-244K | -119.41%-592.04K | -72.60%109.04K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.05%-5.66M | -8.89%-784K | -122.83%-1.1M | -349.39%-3.08M | 80.46%-691.08K | -12.71%-5.44M | 58.37%-720K | -267.41%-495K | 41.76%-685.13K | -98.34%-3.54M |
| Net PPE purchase and sale | -143.48%-3.57M | -10.39%-850K | -6,918.75%-1.12M | -27.91%-780.13K | -1,077.57%-813.87K | -146.59%-1.47M | -115.73%-770K | 94.89%-16K | -69.87%-609.89K | 93.58%-69.11K |
| Net business purchase and sale | 41.19%-2.08M | 120.40%51K | 32.05%-2.16M | -104.52%-137.14K | 105.36%168.14K | 46.98%-3.53M | 96.33%-250K | -1,487.08%-3.18M | 6,428.77%3.03M | -9,040.01%-3.14M |
| Net other investing changes | 96.83%-14K | -95.00%15K | -19.24%2.18M | 30.42%-2.16M | 86.35%-45.35K | 66.29%-442K | 65.92%300K | 5,426.36%2.7M | -303.73%-3.11M | 50.54%-332.28K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.05%-5.66M | -8.89%-784K | -122.83%-1.1M | -349.39%-3.08M | 80.46%-691.08K | -12.71%-5.44M | 58.37%-720K | -267.41%-495K | 41.76%-685.13K | -98.34%-3.54M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -187.47%-5.6M | 31.95%-1.03M | -620.73%-1.01M | -889.67%-1.37M | -174.18%-2.19M | -161.12%-1.95M | -124.40%-1.52M | 121.90%193K | 116.69%173.65K | 27.56%-798.65K |
| Net issuance payments of debt | -177.14%-5.4M | 45.21%-830K | -620.73%-1.01M | -1,193.34%-2.16M | -206.67%-1.41M | 76.93%-1.95M | 76.27%-1.52M | 121.83%193K | 83.98%-166.66K | 58.42%-458.35K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---2.33K | ---- | ---- | ---- | ---- | --0 |
| Net other financing activities | ---201K | ---- | ---- | ---- | -129.75%-781.86K | ---- | ---- | ---89.82K | --1.34M | ---340.3K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -187.47%-5.6M | 31.95%-1.03M | -620.73%-1.01M | -889.67%-1.37M | -174.18%-2.19M | -161.12%-1.95M | -124.40%-1.52M | 121.90%193K | 116.69%173.65K | 27.56%-798.65K |
| Net cash flow | ||||||||||
| Beginning cash position | -46.96%4.63M | 30.17%3.7M | 34.25%4.55M | 7.40%4.83M | -46.96%4.62M | 46.95%8.72M | -21.53%2.84M | -20.80%3.39M | 30.40%4.49M | 46.96%8.72M |
| Current changes in cash | 111.18%458K | -22.46%1.38M | -55.49%-849K | 75.07%-275.16K | 104.76%201.16K | -246.97%-4.1M | -65.05%1.78M | 16.72%-546K | -232.31%-1.1M | -69.89%-4.23M |
| End cash Position | 9.90%5.08M | 9.90%5.08M | 30.17%3.7M | 34.25%4.55M | 7.40%4.83M | -46.96%4.63M | -46.96%4.63M | -21.53%2.84M | -20.80%3.39M | 30.40%4.49M |
| Free cash from | 346.55%8.15M | -27.73%2.35M | 152.31%136K | 382.45%3.39M | 5,580.56%2.27M | 8.08%1.82M | 1,067.97%3.25M | -2,644.03%-260K | -144.65%-1.2M | 105.88%39.93K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.